Recently, the Biomedicine Valley Investment Environment Promotion Conference sponsored by the Nanjing Municipal Government was informed that after the completion of the accumulation of chemical companies in Nanjing Chemical Industry Park, during the “Twelfth Five-Year Plan†period, the city’s biopharmaceutical companies must also gather in the Nanjing Biomedicine Valley. Realize a production value of 50 billion yuan. The move marks the official opening of the new round of industrial upgrading in the city.
On the same day, Nanjing Biopharm was unveiled, and four agreements including the Nanjing University-Nanjing Institute of Biomedical Research and the Nanjing High-tech Industrial Development Zone Administrative Committee were jointly established. A total of 3 billion yuan in investment in Kerry Bo, Intermediate Research and Development Center and other six projects announced the development of the valley.
On the same day, Nanjing Biopharm was unveiled, and four agreements including the Nanjing University-Nanjing Institute of Biomedical Research and the Nanjing High-tech Industrial Development Zone Administrative Committee were jointly established. A total of 3 billion yuan in investment in Kerry Bo, Intermediate Research and Development Center and other six projects announced the development of the valley.
Hunan Kangfutai Medical Devices Co., Ltd. , https://www.3kfut.com